Pharma-Bio Serv, Inc. (PBSV)
USD 0.46
(-9.8%)
USD 0.46
(-9.8%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.77 Million USD | -7.77% |
| 2022 | 4.09 Million USD | -18.25% |
| 2021 | 5 Million USD | -30.48% |
| 2020 | 7.2 Million USD | 19.53% |
| 2019 | 6.02 Million USD | 17.81% |
| 2018 | 5.11 Million USD | 219.12% |
| 2017 | 1.6 Million USD | -26.73% |
| 2016 | 2.18 Million USD | 0.54% |
| 2015 | 2.17 Million USD | -19.42% |
| 2014 | 2.7 Million USD | -16.45% |
| 2013 | 3.23 Million USD | 13.04% |
| 2012 | 2.85 Million USD | 9.31% |
| 2011 | 2.61 Million USD | 75.73% |
| 2010 | 1.48 Million USD | 9.51% |
| 2009 | 1.35 Million USD | -66.52% |
| 2008 | 4.06 Million USD | -45.1% |
| 2007 | 7.39 Million USD | -17.77% |
| 2006 | 8.99 Million USD | 0.0% |
| 2005 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 5.07 Million USD | 34.42% |
| 2024 Q3 | 2.63 Million USD | -11.43% |
| 2024 Q2 | 2.97 Million USD | -41.45% |
| 2023 FY | 3.77 Million USD | -7.77% |
| 2023 Q2 | 3.94 Million USD | 0.87% |
| 2023 Q1 | 3.91 Million USD | -4.48% |
| 2023 Q3 | 4.11 Million USD | 4.23% |
| 2023 Q4 | 3.77 Million USD | -8.17% |
| 2022 Q2 | 4.26 Million USD | -8.12% |
| 2022 Q3 | 4.18 Million USD | -2.02% |
| 2022 FY | 4.09 Million USD | -18.25% |
| 2022 Q4 | 4.09 Million USD | -2.08% |
| 2022 Q1 | 4.64 Million USD | -7.26% |
| 2021 Q3 | 4.75 Million USD | -25.14% |
| 2021 FY | 5 Million USD | -30.48% |
| 2021 Q2 | 6.34 Million USD | -28.7% |
| 2021 Q4 | 5 Million USD | 5.33% |
| 2021 Q1 | 8.9 Million USD | 23.67% |
| 2020 Q4 | 7.2 Million USD | -4.19% |
| 2020 FY | 7.2 Million USD | 19.53% |
| 2020 Q1 | 5.02 Million USD | -16.56% |
| 2020 Q2 | 6.83 Million USD | 35.93% |
| 2020 Q3 | 7.51 Million USD | 9.99% |
| 2019 FY | 6.02 Million USD | 17.81% |
| 2019 Q1 | 4.59 Million USD | -10.12% |
| 2019 Q2 | 4.29 Million USD | -6.53% |
| 2019 Q3 | 4.46 Million USD | 3.8% |
| 2019 Q4 | 6.02 Million USD | 35.09% |
| 2018 Q4 | 5.11 Million USD | 11.46% |
| 2018 Q3 | 4.58 Million USD | 2.22% |
| 2018 Q2 | 4.48 Million USD | 5.85% |
| 2018 Q1 | 4.24 Million USD | 164.61% |
| 2018 FY | 5.11 Million USD | 219.12% |
| 2017 FY | 1.6 Million USD | -26.73% |
| 2017 Q3 | 1.46 Million USD | 3.55% |
| 2017 Q2 | 1.41 Million USD | -11.43% |
| 2017 Q1 | 1.6 Million USD | -26.74% |
| 2017 Q4 | 1.6 Million USD | 9.05% |
| 2016 Q4 | 2.18 Million USD | 28.26% |
| 2016 Q2 | 1.79 Million USD | 16.32% |
| 2016 Q1 | 1.54 Million USD | -29.17% |
| 2016 FY | 2.18 Million USD | 0.54% |
| 2016 Q3 | 1.7 Million USD | -4.85% |
| 2015 Q3 | 1.81 Million USD | -11.19% |
| 2015 FY | 2.17 Million USD | -19.42% |
| 2015 Q1 | 2.26 Million USD | -16.2% |
| 2015 Q2 | 2.03 Million USD | -9.92% |
| 2015 Q4 | 2.17 Million USD | 20.19% |
| 2014 FY | 2.7 Million USD | -16.45% |
| 2014 Q2 | 2.53 Million USD | 8.25% |
| 2014 Q3 | 2.36 Million USD | -6.55% |
| 2014 Q4 | 2.7 Million USD | 14.21% |
| 2014 Q1 | 2.33 Million USD | -27.69% |
| 2013 Q4 | 3.23 Million USD | 38.7% |
| 2013 Q3 | 2.33 Million USD | -8.46% |
| 2013 Q2 | 2.54 Million USD | 12.0% |
| 2013 Q1 | 2.27 Million USD | -20.51% |
| 2013 FY | 3.23 Million USD | 13.04% |
| 2012 Q1 | 2.14 Million USD | -17.92% |
| 2012 Q2 | 1.97 Million USD | -7.84% |
| 2012 Q3 | 2.16 Million USD | 9.38% |
| 2012 Q4 | 2.85 Million USD | 32.1% |
| 2012 FY | 2.85 Million USD | 9.31% |
| 2011 Q1 | 1.68 Million USD | 13.37% |
| 2011 FY | 2.61 Million USD | 75.73% |
| 2011 Q4 | 2.61 Million USD | 27.34% |
| 2011 Q3 | 2.05 Million USD | -8.81% |
| 2011 Q2 | 2.25 Million USD | 33.48% |
| 2010 FY | 1.48 Million USD | 9.51% |
| 2010 Q2 | 1.38 Million USD | 5.28% |
| 2010 Q3 | 1.49 Million USD | 8.22% |
| 2010 Q1 | 1.31 Million USD | -3.38% |
| 2010 Q4 | 1.48 Million USD | -0.52% |
| 2009 Q2 | 1.68 Million USD | 3.77% |
| 2009 FY | 1.35 Million USD | -66.52% |
| 2009 Q4 | 1.35 Million USD | -28.17% |
| 2009 Q3 | 1.89 Million USD | 12.45% |
| 2009 Q1 | 1.62 Million USD | -60.06% |
| 2008 Q1 | 7.53 Million USD | 1.9% |
| 2008 Q3 | 4.37 Million USD | -3.91% |
| 2008 Q2 | 4.55 Million USD | -39.52% |
| 2008 FY | 4.06 Million USD | -45.1% |
| 2008 Q4 | 4.06 Million USD | -7.29% |
| 2007 Q1 | 6.69 Million USD | -25.61% |
| 2007 Q2 | 6.92 Million USD | 3.44% |
| 2007 Q3 | 6.77 Million USD | -2.07% |
| 2007 Q4 | 7.39 Million USD | 9.13% |
| 2007 FY | 7.39 Million USD | -17.77% |
| 2006 Q4 | 8.99 Million USD | 5.27% |
| 2006 Q2 | 8.98 Million USD | 0.76% |
| 2006 FY | 8.99 Million USD | 0.0% |
| 2006 Q3 | 8.54 Million USD | -4.93% |
| 2006 Q1 | 8.91 Million USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Achiko AG | 6.49 Million USD | 41.913% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 8.37 Million USD | 54.908% |
| Cannabis Sativa, Inc. | 1.26 Million USD | -198.875% |
| CompuMed, Inc. | 1.34 Million USD | -180.633% |
| CompuGroup Medical SE & Co. KGaA | 1.45 Billion USD | 99.741% |
| Cogstate Limited | 16.91 Million USD | 77.682% |
| CareView Communications, Inc. | 40.52 Million USD | 90.684% |
| Craneware plc | 215.06 Million USD | 98.245% |
| Caduceus Software Systems Corp. | 5.57 Million USD | 32.28% |
| Certive Solutions Inc. | 10.95 Million USD | 65.543% |
| Drug Free Solution, Inc. | 333.29 Thousand USD | -1032.699% |
| DATATRAK International, Inc. | 6.18 Million USD | 38.914% |
| Strainsforpains, Inc. | 2.61 Million USD | -44.606% |
| Healixa Inc. | 10.57 Million USD | 64.297% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 138.29 Thousand USD | -2629.97% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 1.02 Million USD | -269.212% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 5068.58 USD | -74383.899% |
| IQ-AI Limited | 796.65 Thousand USD | -373.889% |
| Cannabiz Mobile, Inc. | 559.05 Thousand USD | -575.3% |
| Mednow Inc. | 9.46 Million USD | 60.13% |
| Galileo Life Sciences, Inc. | 725.46 Thousand USD | -420.393% |
| MediXall Group, Inc. | 4.53 Million USD | 16.686% |
| Mitesco, Inc. | 14.13 Million USD | 73.291% |
| MobileSmith, Inc. | 6.15 Million USD | 38.661% |
| NantHealth, Inc. | 384.94 Million USD | 99.019% |
| Net Medical Xpress Solutions, Inc. | 1.07 Million USD | -250.211% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 11.33 Million USD | 66.685% |
| Patient Access Solutions, Inc. | 2.44 Million USD | -54.474% |
| PPJ Healthcare Enterprises, Inc. | 7.03 Million USD | 46.368% |
| Medical Cannabis Payment Solutions, Inc. | 2.36 Million USD | -59.578% |
| Renalytix Plc | 15.82 Million USD | 76.145% |
| Revium Recovery Inc. | 144 Thousand USD | -2521.719% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 3.06 Million USD | -23.266% |
| Vaso Corporation | 48.91 Million USD | 92.282% |
| Vynleads, Inc. | 805.33 Thousand USD | -368.786% |